Get the Stockscreener App
5.05
2.64%
0.13
Sophia Genetics Sa stock is traded at $5.05, with a volume of 94,478.
It is up +2.64% in the last 24 hours and up +7.91% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$4.92
Open:
$4.94
24h Volume:
94,478
Relative Volume:
0.87
Market Cap:
$342.63M
Revenue:
$64.49M
Net Income/Loss:
$-71.40M
P/E Ratio:
-4.633
EPS:
-1.09
Net Cash Flow:
$-52.00M
1W Performance:
+2.43%
1M Performance:
+7.91%
6M Performance:
+68.33%
1Y Performance:
+48.75%
1-Day Range:
$4.93
$5.18
1-Week Range:
$4.54
$5.29
52-Week Range:
$2.58
$5.30
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
5.05 | 333.81M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
242.28 | 39.67B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.31 | 13.33B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
51.31 | 9.70B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.43 | 8.50B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.25 | 6.74B | 906.14M | -52.62M | 89.62M | -0.3621 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
321,527 Shares in SOPHiA GENETICS SA $SOPH Purchased by Archon Capital Management LLC - Defense World
SOPHiA GENETICS : Tyrolpath Adopts MSK-IMPACT®-Flex powered with SOPHiA DDM™ to Expand Precision Oncology in Austria - marketscreener.com
Is SOPHiA GENETICS SA (90B) stock vulnerable to rate hikesQuarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Can SOPHiA GENETICS SA stock sustain free cash flow growthWeekly Trend Recap & Real-Time Buy Signal Alerts - Newser
Can SOPHiA GENETICS SA stock resist market sell offs2025 Market Overview & Technical Confirmation Alerts - Newser
Why hedge funds are buying SOPHiA GENETICS SA stock2025 Earnings Surprises & Stock Portfolio Risk Control - Newser
Can SOPHiA GENETICS SA (90B) stock sustain institutional flows2025 Year in Review & Fast Entry High Yield Stock Tips - Newser
Is SOPHiA GENETICS SA a good long term investmentShort-Term Trading Alerts & Rapid Portfolio Trading - earlytimes.in
Sophia Genetics (SOPH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Ensign Peak Advisors Inc Takes $775,000 Position in SOPHiA GENETICS SA $SOPH - MarketBeat
Can SOPHiA GENETICS SA stock maintain growth trajectoryJuly 2025 Retail & Consistent Profit Trading Strategies - moha.gov.vn
Revenue per share of SOPHiA GENETICS SA – FWB:90B - TradingView
SOPHiA GENETICS SA (SOPH) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
EBITDA per share of SOPHiA GENETICS SA – FWB:90B - TradingView
Why SOPHiA GENETICS SA (90B) stock attracts wealthy investors2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Is SOPHiA GENETICS SA (90B) stock bottoming after sell offShare Buyback & Consistent Return Strategy Ideas - newser.com
Will SOPHiA GENETICS SA stock outperform growth indexes - newser.com
How SOPHiA GENETICS SA stock performs in rate cut cyclesEarnings Risk Report & Detailed Earnings Play Strategies - newser.com
Will SOPHiA GENETICS SA (90B) stock deliver stable dividendsWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
Why SOPHiA GENETICS SA (90B) stock could be top winnerMarket Sentiment Review & Long-Term Safe Return Strategies - newser.com
Applying big data sentiment scoring on SOPHiA GENETICS SAJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
Can a trend reversal in SOPHiA GENETICS SA lead to recoveryRate Hike & Fast Gaining Stock Reports - newser.com
Why SOPHiA GENETICS SA (90B) stock could rally stronglyTrade Performance Summary & Precise Buy Zone Tips - newser.com
What is the fair value estimate for SOPHiA GENETICS SA (90B) stock in 2025July 2025 Review & Target Return Focused Picks - newser.com
How SOPHiA GENETICS SA (90B) stock benefits from digital adoptionAnalyst Upgrade & Free Real-Time Market Sentiment Alerts - newser.com
Why SOPHiA GENETICS SA stock remains a top recommendationLong Setup & Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-11-19 02:05:46 - newser.com
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.34%
1.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):